New technology is bringing life-changing esophageal cancer treatment to patients at Norton Audubon Hospital. William B. Evans III, M.D., gastroenterologist with Norton Gastroenterology Consultants of Louisville, is the first and only physician in Louisville to offer truFreeze spray cryotherapy for patients with esophageal cancer. “I’m proud to be the first in the city to provide…
When patients present with cardiac symptoms, choosing the right cardiac diagnostic test depends on risk stratification, symptom frequency and clinical context. Here is a practical guide to navigating cardiology testing in primary care, adapted from a continuing medical education presentation by Mostafa O. El-Refai, M.D., interventional cardiologist with Norton Heart & Vascular Institute. Chest pain:…
Sports preparticipation exams are critical opportunities to identify young athletes at risk for sudden cardiac arrest, which is the leading cause of death in young athletes during sports. While sudden cardiac arrest in children is less common than in adults (3 to 8 per 100,000, compared with 52 per 100,000), the stakes remain high when…
Cardiometabolic care is undergoing a transformation that includes the rise of prescribing GLP-1 receptor agonists as multisystem therapeutics. “Treating diabetes, cardiovascular disease and renal or hepatic dysfunction as isolated conditions is now an outdated approach in cardiometabolic care,” said Catrina R. Hancock, PA-C, physician assistant with Norton Heart & Vascular Institute. “Instead, treatment has shifted…
This continuing medical education presentation features Norton Heart & Vascular Institute electrophysiologist Megan E. Gruber, D.O., discussing critical updates in atrial fibrillation (A-fib) treatment based on the latest guideline revisions. Dr. Gruber provides clinicians with practical insights into the evolving approach to A-fib management, including refined classification systems that mirror heart failure staging, enhanced focus…
Dementia care is experiencing a revolutionary shift. For decades, physicians had little to offer patients beyond symptomatic treatments and supportive care. Today, the medical community stands at the edge of a new era — one defined by precise biomarker testing and disease-modifying therapies that represent genuine new treatments for Alzheimer’s disease. Understanding the new treatment…